Skip to content
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Orthopedics · Familial Avascular Necrosis of the Femoral Head

Long-term Management and Life After Surgery

At a Glance

Long-term management of Familial Avascular Necrosis of the Femoral Head (FANFH) requires protecting hip implants through low-impact activities, avoiding steroids and excess alcohol, and seeking genetic counseling due to a 50% chance of passing the condition to children.

Managing Familial Avascular Necrosis of the Femoral Head (FANFH) is not just about the surgery itself, but about the decades that follow. Because this condition often requires treatment in early adulthood, life after surgery involves a long-term commitment to surveillance, avoiding risk factors, and family planning.

Avoiding Secondary Triggers

Because your genetic blueprint makes your bones highly susceptible to necrosis, it is absolutely critical to avoid secondary factors that accelerate bone death. Even with surgery, avoiding these triggers is vital for protecting your other hip and joints:

  • High-Dose Corticosteroids: Steroids (like prednisone) are a major cause of avascular necrosis in the general population. For someone with FANFH, taking high doses of steroids can be devastating to joint health. Always inform your doctors about your genetic condition before accepting steroid prescriptions [1].
  • Excessive Alcohol Consumption: High alcohol intake is another primary trigger for bone death and must be strictly minimized to protect your joints [2].

Life with a Hip Replacement at a Young Age

For many with FANFH, a Total Hip Arthroplasty (THA) is the key to regaining a pain-free life [3]. While modern materials like highly cross-linked polyethylene and ceramic have drastically improved how long these joints last, young patients must plan for the long haul [4][5].

  • Implant Longevity: Most modern hip replacements are designed to last 15 to 25 years or more [6]. However, because you are young and likely more active than the average replacement patient, the prosthetic may wear down faster than it would in an older person [4].
  • Activity Modifications: To maximize the lifespan of your implant, doctors generally recommend avoiding high-impact activities that involve repetitive jumping or pounding (like long-distance running or high-intensity basketball) [6]. Switching to low-impact exercises—such as swimming, cycling, or rowing—can significantly reduce the wear on the prosthetic components.
  • Future Revisions: It is a reality for young FANFH patients that they may need a revision surgery (a procedure to replace a worn-out part of the prosthetic) later in life [7]. Maintaining a healthy weight and following activity guidelines are the best ways to delay this second surgery.

Genetic Counseling and Family Planning

Since FANFH is caused by a mutation in the COL2A1 gene, it is an autosomal dominant condition [8]. This means there is a 50% chance of passing the mutation to each child [9][10].

Genetic counseling is highly recommended for all families affected by FANFH. A counselor can help you:

  • Identify the specific mutation in your family’s blueprint [11].
  • Understand why symptoms can vary so much—even between siblings with the same mutation [12].
  • Navigate the emotional and practical aspects of family planning, including options for screening children early before they develop symptoms [10].

The Psychological Toll

Living with a genetic disease carries a unique emotional weight. It is common for patients to experience “guilt” about passing the gene to their children or “scan-xiety” before routine follow-up appointments [13][14]. Many patients find it helpful to join support groups for rare bone diseases or seek counseling from professionals who specialize in chronic health conditions [13]. Focusing on what you can control—like your activity choices and screening schedule—can help manage this stress.

Routine Monitoring and Surveillance

Regardless of whether you have had joint-preserving surgery or a full replacement, life-long monitoring is required.

  1. Bilateral Monitoring: Because FANFH has a high likelihood of affecting both hips, routine MRI or X-ray imaging of your asymptomatic hip is essential to catch any early signs of bone death [15].
  2. Clinical Follow-up: Even if you feel perfect, you will need periodic X-rays (often every 1 to 5 years) of your surgical hip to ensure the implant is not loosening or wearing down “silently” [16].
  3. Family Screening: If you have children, discuss a screening protocol with a pediatric orthopedic specialist. Early detection via MRI can catch the disease in the “pre-collapse” stage, potentially opening the door for joint-preserving treatments that were not available to previous generations [17].

Common questions in this guide

How long will a hip replacement last for someone with FANFH?
Modern hip replacements are typically designed to last 15 to 25 years or more. However, because young patients tend to be more active, the prosthetic may wear down faster and eventually require a revision surgery.
What activities should I avoid after hip replacement surgery?
Doctors generally recommend avoiding high-impact activities that involve repetitive jumping or pounding, such as long-distance running or basketball. Switching to low-impact exercises like swimming or cycling helps reduce wear on the hip implant.
Is there a chance I will pass FANFH to my children?
Yes, FANFH is an autosomal dominant genetic condition caused by a COL2A1 gene mutation. This means there is a 50 percent chance of passing the mutation to each of your children.
Why do I need to monitor my other hip if it does not hurt?
FANFH has a high likelihood of eventually affecting both hips. Routine imaging of your pain-free hip is essential to catch any early signs of bone death so that joint-preserving treatments can be considered before the bone collapses.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How many years can I realistically expect my current hip replacement to last given my age and activity level?
  2. 2.What specific activity modifications (e.g., avoiding high-impact running) do you recommend to maximize the life of the implant?
  3. 3.How frequently do I need follow-up X-rays to check for 'silent' wear or loosening of the prosthetic?
  4. 4.Are there non-hip related symptoms, such as eye or ear issues, that we should be monitoring because of my COL2A1 mutation?
  5. 5.When and how should I begin screening my children for early signs of the disease?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (17)
  1. 1

    MMP-14 single-nucleotide polymorphisms are related to steroid-induced osteonecrosis of the femoral head in the population of northern China.

    Qi Y, Wang J, Sun M, et al.

    Molecular genetics & genomic medicine 2019; (7(2)):e00519 doi:10.1002/mgg3.519.

    PMID: 30548828
  2. 2

    IGF-1 polymorphisms modulate the susceptibility to osteonecrosis of the femoral head among Chinese Han population.

    Wang J, Liu H, Zhang Q

    Medicine 2019; (98(23)):e15921 doi:10.1097/MD.0000000000015921.

    PMID: 31169709
  3. 3

    [Total hip replacement in avascular femoral head necrosis].

    Betsch M, Tingart M, Driessen A, et al.

    Der Orthopade 2018; (47(9)):751-756 doi:10.1007/s00132-018-3617-5.

    PMID: 30094647
  4. 4

    Long-Term Survivorship of Total Hip Arthroplasty with Highly Cross-Linked Polyethylene for Osteonecrosis.

    Hart A, Janz V, Trousdale RT, et al.

    The Journal of bone and joint surgery. American volume 2019; (101(17)):1563-1568 doi:10.2106/JBJS.18.01218.

    PMID: 31483399
  5. 5

    Outcomes of total hip arthroplasty in patients with osteonecrosis of the femoral head-a current review.

    Pierce TP, Elmallah RK, Jauregui JJ, et al.

    Current reviews in musculoskeletal medicine 2015; (8(3)):246-51 doi:10.1007/s12178-015-9283-x.

    PMID: 26045086
  6. 6

    Outcomes after total hip arthroplasty in young patients with osteonecrosis of the hip.

    Swarup I, Shields M, Mayer EN, et al.

    Hip international : the journal of clinical and experimental research on hip pathology and therapy 2017; (27(3)):286-292 doi:10.5301/hipint.5000457.

    PMID: 28165595
  7. 7

    Total hip arthroplasty in young patients with post-traumatic arthritis of the hip.

    Swarup I, Sutherland R, Burket JC, Figgie MP

    Hip international : the journal of clinical and experimental research on hip pathology and therapy 2017; (27(6)):546-550 doi:10.5301/hipint.5000499.

    PMID: 28574124
  8. 8

    COL2A1 mutation (c.3508G>A) leads to avascular necrosis of the femoral head in a Chinese family: A case report.

    Liu F, Xiong Z, Liu Q, et al.

    Molecular medicine reports 2018; (18(1)):254-260 doi:10.3892/mmr.2018.8984.

    PMID: 29750297
  9. 9

    A novel type II collagen gene mutation in a family with spondyloepiphyseal dysplasia and extensive intrafamilial phenotypic diversity.

    Nakashima Y, Sakamoto Y, Nishimura G, et al.

    Human genome variation 2016; (3()):16007 doi:10.1038/hgv.2016.7.

    PMID: 27274858
  10. 10

    Parental somatogonadal COL2A1 mosaicism contributes to intrafamilial recurrence in a family with type 2 collagenopathy.

    Yamamoto K, Kubota T, Takeyari S, et al.

    American journal of medical genetics. Part A 2020; (182(3)):454-460 doi:10.1002/ajmg.a.61422.

    PMID: 31854518
  11. 11

    Diagnosis of Prenatal-Onset Achondrogenesis Type II by a Multidisciplinary Assessment: A Retrospective Study of 2 Cases.

    Wang W, Wu Q, Sun L, et al.

    Case reports in obstetrics and gynecology 2019; (2019()):7981767 doi:10.1155/2019/7981767.

    PMID: 31392067
  12. 12

    Radiologic Features of Type II and Type XI Collagenopathies.

    Handa A, Grigelioniene G, Nishimura G

    Radiographics : a review publication of the Radiological Society of North America, Inc 2021; (41(1)):192-209 doi:10.1148/rg.2021200075.

    PMID: 33186059
  13. 13

    Mental health conditions, physical functioning, and health-related quality of life in adults with a skeletal dysplasia: a cross-sectional multinational study.

    Fagereng E, Htwe S, McDonald S, et al.

    Orphanet journal of rare diseases 2025; (20(1)):116 doi:10.1186/s13023-025-03610-w.

    PMID: 40069831
  14. 14

    Prevalence of mental health conditions and pain in adults with skeletal dysplasia.

    Jennings SE, Ditro CP, Bober MB, et al.

    Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2019; (28(6)):1457-1464 doi:10.1007/s11136-019-02102-2.

    PMID: 30637564
  15. 15

    Accuracy of MRI diagnosis of early osteonecrosis of the femoral head: a meta-analysis and systematic review.

    Zhang YZ, Cao XY, Li XC, et al.

    Journal of orthopaedic surgery and research 2018; (13(1)):167 doi:10.1186/s13018-018-0836-8.

    PMID: 29973239
  16. 16

    Short term evaluation of total hip arthroplasty; our experience at tertiary care center.

    Saeed UB, Ahmad Khan RD, Zain-Ur-Rehman M, Yasin A

    JPMA. The Journal of the Pakistan Medical Association 2015; (65(11 Suppl 3)):S190-4.

    PMID: 26878518
  17. 17

    Identification of an IGF1 mutation (c.15+3G>A) in familial osteonecrosis of the femoral head: A case report.

    Xu Q, Song D, Wu Z, et al.

    Medicine 2021; (100(1)):e23705 doi:10.1097/MD.0000000000023705.

    PMID: 33429739

This page provides educational information about living with FANFH after surgery. Always consult your orthopedic surgeon and genetic counselor for personalized medical advice, activity guidelines, and family planning.

Get notified when new evidence is published on Familial avascular necrosis of femoral head.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.